logo

Lyell Immunopharma Inc (LYEL) Stock: A Year of Stock Market Dynamics

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lyell Immunopharma Inc’s current trading price is -49.87% away from its 52-week high, while its distance from the 52-week low is 50.76%. The stock’s price range over this period has fluctuated between $1.32 and $3.97. The company, operating within the financial sector, had a trading volume of approximately 2.14 million for the day, which was noticeably higher than the average daily share volume of 1.04 million over the last 3 months.

Lyell Immunopharma Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $3.97 on 06/16/23 and a low of $1.32 for the same time frame on 10/09/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Lyell Immunopharma Inc (LYEL) has experienced a quarterly rise of 3.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 505.66M and boasts a workforce of 224 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.04, with a change in price of +0.37. Similarly, Lyell Immunopharma Inc recorded 1,178,234 in trading volume during the last 100 days, posting a change of +22.84%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for LYEL stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.09.

LYEL Stock Stochastic Average

Today’s raw stochastic average for Lyell Immunopharma Inc over the last 50 days is 19.16%.This indicates a increase from the raw stochastic average of the past 20 days, which was 10.60%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 15.61% and 22.74%, respectively.

LYEL Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant gain of 2.58% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 22.84%. Over the past 30 days, the price of LYEL has fallen by 6.99%. And in the last five days, it has fallen by -8.72%.